Cargando…

Cancer immunotherapy: Moving beyond checkpoint inhibition

Detalles Bibliográficos
Autor principal:	Boes, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290967/ https://www.ncbi.nlm.nih.gov/pubmed/30564293 http://dx.doi.org/10.18632/oncotarget.26384

Ejemplares similares

Moving beyond COVID
por: Tandon, Rajiv
Publicado: (2022)

Moving cancer immunotherapy forward through the Journal for ImmunoTherapy of Cancer (JITC)
por: Romero, Pedro
Publicado: (2019)

Cancer immunotherapy beyond immune checkpoint inhibitors
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018)

Cancer Treatment in CKD: Time to Move Beyond Renalism
por: Berger, Joseph Rossi, et al.
Publicado: (2023)

COVID‐19: Moving beyond the pandemic
por: McPeake, Joanne, et al.
Publicado: (2020)

Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
por: Hoare, Joseph, et al.
Publicado: (2018)

Nosocomial Meningitis: Moving beyond Description to Prevention
por: Kim, Hong Bin
Publicado: (2012)

Effective LARC Providers: Moving Beyond Training
por: Shelton, James D, et al.
Publicado: (2016)

Care programme approach – time to move beyond?
por: Kingdon, David
Publicado: (2019)

Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
por: Hida, Toyoaki, et al.
Publicado: (2020)

Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
por: Wilkinson, Robert W., et al.
Publicado: (2018)

Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors
por: Catalano, Martina, et al.
Publicado: (2022)

Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors
por: Abdou, Yara, et al.
Publicado: (2022)

Effective LARC Providers: Moving Beyond Training (Republication)
por: Shelton, James D, et al.
Publicado: (2016)

Resistance to Checkpoint Inhibition in Cancer Immunotherapy
por: Barrueto, Luisa, et al.
Publicado: (2020)

Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?
por: Silkensen, Shannon L., et al.
Publicado: (2018)

Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancer
por: Bell, R. Bryan, et al.
Publicado: (2022)

Concussion research: Moving beyond the natural history
por: Buckley, Thomas A.
Publicado: (2021)

Wildlife, Reservoir of Zoonotic Agents: Moving beyond Denial and Fear
por: Davoust, Bernard, et al.
Publicado: (2023)

Advancing together and moving forward: Combination gene and cellular immunotherapies
por: Priceman, Saul J., et al.
Publicado: (2022)

Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
por: Abushukair, Hassan Mohammed, et al.
Publicado: (2022)

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
por: Qin, Shuang, et al.
Publicado: (2019)

The Neglected Diseases Section in PLoS Medicine: Moving Beyond Tropical Infections
Publicado: (2008)

Successful recovery after major surgery: moving beyond length of stay
por: Miller, Timothy E, et al.
Publicado: (2014)

Diagnostic errors: moving beyond ‘no respect’ and getting ready for prime time
por: Singh, Hardeep
Publicado: (2013)

Comparing alcohol with tobacco indicates that it is time to move beyond tobacco exceptionalism
por: McCambridge, Jim, et al.
Publicado: (2019)

Tuberculosis diagnostic networks: Moving beyond the laboratory to end tuberculosis in Africa
por: Piatek, Amy
Publicado: (2017)

Palliative Care for Patients With Advanced CKD: Moving Beyond the Status Quo
por: Lu, Emily, et al.
Publicado: (2019)

EUS-guided biliary drainage: Moving beyond the cliché of prime time
por: Dhir, Vinay, et al.
Publicado: (2019)

Dynamism of the Human Lung Proteome during Alveolarization: Moving beyond the Transcriptome
por: Alvira, Cristina M.
Publicado: (2021)

Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint
por: Faltermeier, Claire M., et al.
Publicado: (2021)

TIGIT: an immune checkpoint beyond T cells in chronic lymphocytic leukemia
por: Seiffert, Martina
Publicado: (2023)

Moving Beyond the Mouse: Key New Insight Into Human Colonic Dendritic Cells
por: Denning, Timothy L.
Publicado: (2015)

Life after death: RIP1 and RIP3 move beyond necroptosis
por: Berger, SB, et al.
Publicado: (2016)

Moving Beyond the Confines of Body Mass Index in the Quest to Understand Obese Asthma
por: Forno, Erick
Publicado: (2020)

It’s Time to Move Beyond Traditional Health Care Worker Training Approaches
por: Bluestone, Julia, et al.
Publicado: (2021)

Moving Beyond PM(2.5) Mass to More Effectively Protect Health
por: Thurston, George D.
Publicado: (2023)

Changing the Face of Cardiovascular Trial Participation: Moving Beyond Middle-Aged White Guys
por: Waters, David D.
Publicado: (2021)

Understanding Sex-based Differences in Intensive Care Unit Mortality: Moving Beyond the Biology
por: Viglianti, Elizabeth M., et al.
Publicado: (2022)

Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle
por: Ren, Xiubao
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8jue4mkhfpqml2h56bp70f56v0